Triple

T8328960
Position Surface form Disambiguated ID Type / Status
Subject Council Directive 2001/86/EC E195027 entity
Predicate shortName P43 FINISHED
Object Directive 2001/86/EC E195027 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Directive 2001/86/EC | Statement: [Council Directive 2001/86/EC, shortName, Directive 2001/86/EC]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Directive 2001/86/EC
Context triple: [Council Directive 2001/86/EC, shortName, Directive 2001/86/EC]
  • A. Directive 2001/82/EC
    Directive 2001/82/EC is a key European Union law that sets out the rules for the authorization, supervision, and pharmacovigilance of veterinary medicinal products across EU member states.
  • B. Council Directive 2001/86/EC chosen
    Council Directive 2001/86/EC is a European Union legal act that supplements the Statute for a European Company (Societas Europaea) by establishing rules on employee involvement in such companies.
  • C. Directive 2001/83/EC
    Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
  • D. Directive 2006/86/EC
    Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
  • E. Directive 2003/41/EC
    Directive 2003/41/EC was the original EU framework setting prudential and supervision rules for institutions for occupational retirement provision (IORPs) before being updated and replaced by the IORP II Directive.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca82e87f2c8190bdb71ee29dfc642d completed March 30, 2026, 2:04 p.m.
NER Named-entity recognition batch_69cb7fb812508190aed8a283dacf712e completed March 31, 2026, 8:03 a.m.
NED1 Entity disambiguation (via context triple) batch_69cdc70723a48190a3e33908fc84fe59 completed April 2, 2026, 1:31 a.m.
Created at: March 30, 2026, 5:56 p.m.